An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Conditions
Colorectal Cancer · CRC (Colorectal Cancer) · Cancer Cachexia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
NGM Clinical Study Site, Los Angeles, California, United States
NGM Clinical Study Site, Los Angeles, California, United States
NGM Clinical Study Site, Santa Rosa, California, United States
NGM Clinical Study Site, Margate, Florida, United States
NGM Clinical Study Site, Baltimore, Maryland, United States
NGM Clinical Study Site, New York, New York, United States
NGM Clinical Study Site, Toledo, Ohio, United States
NGM Clinical Study Site, Youngstown, Ohio, United States
NGM Clinical Study Site, Dallas, Texas, United States
NGM Clinical Study Site, Kingwood, Texas, United States
NGM Clinical Study Site, Laredo, Texas, United States
NGM Clinical Study Site, Richmond, Virginia, United States
NGM Clinical Study Site, Appleton, Wisconsin, United States
NGM Clinical Study Site, Tbilisi, Georgia
NGM Clinical Study Site, Tbilisi, Georgia
NGM Clinical Study Site, Tbilisi, Georgia
NGM Clinical Study Site, Tbilisi, Georgia
NGM Clinical Study Site, Tbilisi, Georgia
NGM Clinical Study Site, Goyang, South Korea
NGM Clinical Study Site, Goyang, South Korea
NGM Clinical Study Site, Incheon, South Korea
NGM Clinical Study Site, Seoul, South Korea
NGM Clinical Study Site, Seoul, South Korea
NGM Clinical Study Site, Seoul, South Korea
NGM Clinical Study Site, Suwon, South Korea
NGM Clinical Study Site, Taichung, Taiwan
NGM Clinical Study Site, Taipei, Taiwan
NGM Clinical Study Site, Taoyuan, Taiwan
Study leads
NGM Study Director
Study Director
NGM Biopharmaceuticals, Inc